Answers are grounded in this paper and cite their sources.
Current guidelines recommend empirical antipseudomonal β-lactam antibiotics for febrile neutropenia with a suspected pulmonary focus, with a potential benefit from extended infusion regimens in high-risk patients. Local resistance patterns and patient-specific factors should guide therapy adjustments.
No takes yet. Share an insight, caveat, or question.
Tripdatabase (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: